Yastremska, 20, provided the sample in November and a WADA lab in Montreal identified the presence of mesterolone metabolite, an anabolic agent on its Prohibited Checklist.
“Yastremska was billed with an Anti-Doping Rule Violation below Short article 2.1 of the Programme (presence of a Prohibited Compound in a Player’s Sample) and was provisionally suspended with impact from Jan. 7,” the ITF reported.
“Yastremska experienced (and retains) the correct to use to the Chair of the Independent Tribunal convened to listen to her case why the Provisional Suspension should really not be imposed, but has preferred not to training that correct to date.”
— Dayana Yastremska (@D_Yastremska) 1610032263000
Yastremska, rated 29 in the earth, denied getting utilized general performance improving medication and thinks the favourable exam was the end result of a “contamination function”.
“I’m astonished and under shock, particularly provided that two weeks prior to this examination… I tested detrimental at the WTA occasion in Linz. Just after this past event of the year, I stopped training to relaxation prior to the begin of the new period,” she explained in a statement.
“Only a pretty very low concentration of mesterolone metabolite was detected in my urine. Provided that low concentration and offered my damaging examination two months before, I have been given scientific information that the final result is dependable with some variety of contamination function.”
The ITF did not say when Yastremska’s listening to would acquire area, putting her participation in the Feb. 8-21 Australian Open up in question.